ESR2 and neoplasm: One study using a single cell line, A431, showed that oestrogen receptors ERα and G‐coupled protein receptor (GPR30, or GPER1) modulated expression of tumour markers Cyclin D1 and CD55; however, ERβ downregulated both tumour markers.105